2026-07-02 — Dutch precision-fermentation protein maker The Protein Brewery closed a $20.5M Series B extension, saying a recent FDA GRAS setback for its…
Dutch precision-fermentation protein maker The Protein Brewery closed a $20.5M Series B extension.
The company said a recent FDA GRAS setback for its Fermotein ingredient won't derail its plans to enter the US market, and framed the fresh capital as a bridge to a resubmission and continued commercial rollout in Europe.
The Protein Brewery raises $20.5M Series B extension despite FDA GRAS setback
Dutch precision-fermentation protein maker The Protein Brewery closed a $20.5M Series B extension, saying a recent FDA GRAS setback for its Fermotein ingredient won't derail its US plans.
Dutch precision-fermentation protein maker The Protein Brewery closed a $20.5M Series B extension.
The company said a recent FDA GRAS setback for its Fermotein ingredient won't derail its plans to enter the US market, and framed the fresh capital as a bridge to a resubmission and continued commercial rollout in Europe.